Strategic Acquisition Ekium Group’s acquisition of Scitech signals strong growth in the life sciences engineering services space, indicating broader client reach and an expanded project pipeline that sales teams can leverage to cross-sell complementary capabilities.

Regulatory Expertise Scitech offers end-to-end regulated project delivery from feasibility to commissioning, with deep regulatory know-how that can address the compliance-heavy needs of pharmaceutical and biotech clients seeking faster time-to-market and reduced risk.

Pharma Partnerships Recent collaborations with leading institutions and centers, such as the Pirbright Institute, highlight opportunities to target vaccine manufacturing, veterinary biotech, and CMC-regulated projects where Scitech’s design, construction, and validation services are critical.

Growth Markets The company’s European footprint, multi-disciplinary engineering capabilities, and focus on complex facilities position it well for expansions into new GMP-compliant plants, bioreactors, and automation-driven modernization programs.

Talent Programs Investments in HR leadership, training partnerships, and graduate programs (Xcellerate) indicate a commitment to talent development, presenting upsell opportunities in training, compliance, and knowledge transfer services for clients expanding teams.